Categories Uncategorized

Research Discovers Wearable Devices Can Detect the Coronavirus

Results from various studies conducted by leading research institutions in the Unites States have found that wearables such as smartwatches, which measure an individual’s heart rate, also possess the ability to identify whether a person is coronavirus positive — even before symptoms start showing or the virus is detected using a test.

These results, which were announced from institutions including Stanford University, California and New York’s Mount Sinai Health System, demonstrate that these devices detect the virus’s presence by measuring the pulse of a person’s heartbeat and their skin temperature as well as other biometric and physiological features.

Some of the devices mentioned in the report include Fitbit and Garmin watches and the Apple Watch. Experts state that the technology these devices use may be useful in the future to help decrease the spread of both the pandemic as well as other transmissible diseases.

A few members of the research team stated that their objective was to utilize the technology available to discover how fast the coronavirus or any other infection could be identified even before laboratory tests were conducted or symptoms begun showing.

Icahn School of Medicine assistant professor Rob Hirten explained that the goal of the study was to detect infections before individuals discovered they were sick or even identify the time an individual became infected. He further explains that the researchers were aware of the inflammatory effect the coronavirus had on the human body, adding that the variability markers of an individual’s heart rate changed as inflammation advanced in the body. This knowledge, he said, could help researchers predict when individuals were infected with a disease.

The researchers stated that to conduct the study, they observed 300 health-care personnel from Mount Sinai who wore Apple Watches over a five-month period, between April 29 and September 29, 2020.

The researchers also quoted a report conducted by the Centers for Disease Control in the U.S., which explained that a considerable amount of transmission takes place by carriers who were asymptomatic. They then noted that their findings would be useful in effectively containing the spread of the coronavirus.

The researchers’ interview, which was conducted by CBS, also highlighted a separate study that demonstrated the difference in the rates of heartbeats of some COVID-19 patients before the disease’s symptoms began showing.  Additionally, alarm systems were developed for the wearable devices, which would notify a wearer about their heartbeat rates while also ensuring they kept a distance from individuals who had shown any signs of infection.

In most cases, the body may have a fighting chance against different diseases if matters of nutrition are accorded the attention they deserve. Nutrition and nutrients are a top priority for MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FRA: 0C0), a company that focuses on developing natural crop protection remedies that can reduce or eliminate the use of synthetic chemicals during cultivation.

NOTE TO INVESTORS: The latest news and updates relating to MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FRA: 0C0) are available in the company’s newsroom at https://ibn.fm/MGROF

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

Soligenix Inc. (NASDAQ: SNGX) Strengthens Rare Disease Pipeline Program Through UK Regulatory Innovation Designation

Designations granted by leading global regulatory agencies play a critical role in advancing drug-development programs.…

2 days ago

Oncolytic Virus Therapy is Set to Transform Cancer Care

Enormous resources are being channeled into studying different ways to support the immune system in its fight…

2 days ago

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Advances PP2A Inhibition Strategy in Evolving Oncology Landscape

Recent research shows how chemotherapy and immunotherapy can complement each other when used together. Within…

2 days ago

Study Finds That Marijuana Legalization Lowers Crime Rates

David Eby, the Premier of British Columbia, has revealed that a wide range of American healthcare workers,…

3 days ago

Earth Science Tech Inc. (ETST) Builds Telehealth, Pharmacy Links in Evolving Digital Care

Patients increasingly prefer access, speed and convenience, but healthcare systems also need better coordination, safer…

4 days ago

Soligenix Inc. (NASDAQ: SNGX) Advances Rare Disease Innovation Through Platform Science and Expanding Therapeutic Pipeline

High-quality development platforms and translational research frameworks have become essential tools in rare-disease biotechnology. Soligenix…

4 days ago